In this study, we show that inhibition of furin activity in rhabdomyosarcoma results in delayed tumor growth in vivo, and that loss of furin activity, through RNA interference or application of pan-PC inhibitors decreases migration and invasion in vitro. This evidence concerns the gene FURIN and rhabdomyosarcoma.